Menu ×


Cosmetic Surgery Product Market : Global Demand Analysis & Opportunity Outlook 2021

  • Report ID: 44
  • Text Size:

Extensive insights into the Growth of Cosmetic Surgery Product Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


Cosmetic surgery is an operative procedure which is used to enhance or alter a part of the body or face of an individual. This procedure is widely accepted as a means of improving aesthetic appearance of the body by majority of the world population.  

Cosmetic surgery products are segmented under the global cosmetic surgery and services market which is envisioned to behold a compound annual growth rate (CAGR) of 5.9% to reach USD 28 Billion during 2015-2021. Geographically, the global cosmetic surgery product market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of World.

Market Size and Forecast

At present, North America dominates the global cosmetic surgery products market. With USD 3.0 Billion demand in 2015 (up by annual growth rate of 7.5% from 2014), the U.S. is the largest cosmetic surgery products market in North America.

Europe is the second largest cosmetic surgery product market in the world behind North America. The market in the European region is sparked by increasing popularity of cosmetic procedures in some of the major European countries. For instance, the U.K. accounted for EUR 2.4 Billion of cosmetic surgery procedures market in 2010, which is further anticipated to expand to EUR 3.8 Billion in 2016, registering a CAGR of 7.9%.

Asia-Pacific cosmetic surgery product market is set for a burgeoned growth over the forecast period. The market in the region is believed to get forged from rising per capita incomes in some of the major countries such as India, China and Japan. In addition to this, growing adoption of western culture among majority of the population is also expected to garner the growth of Asia-Pacific cosmetic surgery product market in future. CLICK TO DOWNLOAD FREE SAMPLE

Market Segmentation

By Product Type

The global cosmetic surgery product market is segmented based on product type into the following:

  • Injectables

Based on injectables, global cosmetic surgery product market can be segmented into collagen, botulin toxin and hyaluronic acid.

  • Implants

On the basis of implants, global cosmetic surgery product market is segregated as breast implants, lip implants and cheek and chin implants. The implant segment accounted for 40% of market share in 2015.

  • Equipment

Global cosmetic surgery equipment market is divided on the basis of equipment area into dermal resurfacing lasers, liposuction equipment, hair removal lasers, and light based systems.

By Procedures

The global cosmetic surgery product market is segmented on the basis of procedures into surgical and non-surgical procedures products.

  • Surgical Procedures

The surgical procedures can be further classified as Liposuction, breast augmentation, eyelid surgery, nose surgery and tummy tuck.

  • Non-Surgical Procedures

Non-surgical procedures can be further classified as Botox, hair removal and others.

The study further analysis the Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and challenges

Increasing beauty consciousness amongst the global population coupled with rapidly expanding aging population is expected to be a major growth driver of global cosmetic surgery product market over the forecast period i.e. 2015-2021.

In addition to this, technological innovations in cosmetic surgery products are also believed to garner the growth of global cosmetic surgery product market in future.

However, high cost associated with manufacturing of cosmetic products, rigorous government approvals and growing post-surgery complications related to cosmetic surgery procedures is anticipated to hamper the growth of global cosmetic surgery products market during the forecast period. 

Key Players

Global cosmetic surgery product market is very competitive and includes some of the top players such as Allergan, Inc., Cutera, Inc., Alma Lasers, Ltd., Johnson & Johnson, IRIDEX Corporation, Genesis Biosystems, Inc., Lumenis Ltd., Sanofi S.A. , etc.             


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved